Evaluations of Drug Interactions

About Us|Careers|Contact Us

Home|Products|Evaluations of Drug Interactions

AWP Settlement Update
Clifton Louie, RPh, DPA, to Join First DataBank as Executive Vice President
Webinar - Boosting Usability of CPOE (and eMAR) with Real Physician-Friendly Medication Ordering
Beth Israel Deaconess Medical Center Selects First DataBank’s OrderView to Simplify Discharge Prescriptions, Enhance Medication Reconciliation
The U.S. Department of Veteran Affairs Selects the First DataBank Drug Database for a Prototype Project in its Major System Reengineering Initiative

First DataBank News

Requires Adobe Acrobat

Evaluations of Drug Interactions Datasheet

Products:

Drug-Drug Interaction Module

A Comprehensive Source of Drug Interaction Information

First DataBank's Evaluations of Drug Interactions (EDI) is a comprehensive source of drug-drug interaction information—containing over 43,000 drug interactions on both prescription and over-the-counter drugs.

Exclusively Endorsed by the APhA

Originally developed by the American Pharmaceutical Association (APhA), EDI offers you immediate access to clinically reviewed drug interaction monographs. The APhA exclusively endorses the text, and a scientific panel selected by the APhA stringently reviews each drug interaction monograph. Consulting contributors from various pharmacy practice settings ensure the appropriateness of the information presented.

Drug Interaction Monograph Content

Monographs include the following information:

Title - interacting drugs with generic names
Severity Level - four severity levels indicate potential harm to patient, frequency and predictability of the drug interaction, and degree of available documentation
Summary - overall effects of the drug interaction, and synopsis of the available medical literature
Related Drugs - evaluates agents that are pharmacologically, pharmacokinetically, or structurally related to either of the interacting drugs
Mechanism - description of drug interaction
Recommendations - suggestions for patient monitoring and management of the drug interaction
References - to primary medical literature; includes full titles
Summary Box - most of the monographs include a synopsis of the potential effects of the drug interaction, with recommendations

Timely Information

New product information and drug interactions are incorporated continually, so each EDI update provides the most timely information available. EDI is published as a two-volume loose-leaf textbook. The text is updated six times each year.

Additionally, First DataBank's Drug-Drug Interaction Module (DDIM)—a drug interaction database for integration into healthcare information systems—provides page references exclusively to EDI.